• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B-RAFV600E 抑制诱导人黑色素瘤细胞凋亡涉及 bimS 的选择性剪接。

Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS.

机构信息

Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, Newcastle, New South Wales, Australia.

出版信息

Cell Death Dis. 2010 Sep 2;1(9):e69. doi: 10.1038/cddis.2010.48.

DOI:10.1038/cddis.2010.48
PMID:21364673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3032346/
Abstract

Bim is known to be critical in killing of melanoma cells by inhibition of the RAF/MEK/ERK pathway. However, the potential role of the most potent apoptosis-inducing isoform of Bim, Bim(S), remains largely unappreciated. Here, we show that inhibition of the mutant B-RAF(V600E) triggers preferential splicing to produce Bim(S), which is particularly important in induction of apoptosis in B-RAF(V600E) melanoma cells. Although the specific B-RAF(V600E) inhibitor PLX4720 upregulates all three major isoforms of Bim, Bim(EL), Bim(L), and Bim(S), at the protein and mRNA levels in B-RAF(V600E) melanoma cells, the increase in the ratios of Bim(S) mRNA to Bim(EL) and Bim(L) mRNA indicates that it favours Bim(S) splicing. Consistently, enforced expression of B-RAF(V600E) in wild-type B-RAF melanoma cells and melanocytes inhibits Bim(S) expression. The splicing factor SRp55 appears necessary for the increase in Bim(S) splicing, as SRp55 is upregulated, and its inhibition by small interfering RNA blocks induction of Bim(S) and apoptosis induced by PLX4720. The PLX4720-induced, SRp55-mediated increase in Bim(S) splicing is also mirrored in freshly isolated B-RAF(V600E) melanoma cells. These results identify a key mechanism for induction of apoptosis by PLX4720, and are instructive for sensitizing melanoma cells to B-RAF(V600E) inhibitors.

摘要

Bim 被认为通过抑制 RAF/MEK/ERK 通路在杀死黑色素瘤细胞中起关键作用。然而,Bim 的最有效凋亡诱导同工型 Bim(S) 的潜在作用在很大程度上仍未得到认识。在这里,我们表明抑制突变型 B-RAF(V600E)触发优先剪接以产生 Bim(S),这在 B-RAF(V600E)黑色素瘤细胞中诱导凋亡特别重要。虽然特定的 B-RAF(V600E)抑制剂 PLX4720 在 B-RAF(V600E)黑色素瘤细胞中上调所有三种主要同工型 Bim(EL)、Bim(L)和 Bim(S)的蛋白和 mRNA 水平,但 Bim(S)mRNA 与 Bim(EL)和 Bim(L)mRNA 的比值增加表明它有利于 Bim(S)剪接。一致地,在野生型 B-RAF 黑色素瘤细胞和黑素细胞中强制表达 B-RAF(V600E)抑制 Bim(S)表达。剪接因子 SRp55 似乎是增加 Bim(S)剪接所必需的,因为 SRp55 上调,并且其通过小干扰 RNA 的抑制阻止了 PLX4720 诱导的 Bim(S)和凋亡的诱导。PLX4720 诱导的、SRp55 介导的 Bim(S)剪接增加也反映在新分离的 B-RAF(V600E)黑色素瘤细胞中。这些结果确定了 PLX4720 诱导凋亡的关键机制,并且对于使黑色素瘤细胞对 B-RAF(V600E)抑制剂敏感具有指导意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/ed0ea767ed21/cddis201048f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/1f4af9df6223/cddis201048f1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/c7ea5c2d92e8/cddis201048f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/823da13667b8/cddis201048f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/2110e563641d/cddis201048f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/8906d0c40232/cddis201048f5a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/1e947230a633/cddis201048f6a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/f9b6c07675c6/cddis201048f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/ed0ea767ed21/cddis201048f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/1f4af9df6223/cddis201048f1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/c7ea5c2d92e8/cddis201048f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/823da13667b8/cddis201048f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/2110e563641d/cddis201048f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/8906d0c40232/cddis201048f5a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/1e947230a633/cddis201048f6a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/f9b6c07675c6/cddis201048f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/3032346/ed0ea767ed21/cddis201048f8.jpg

相似文献

1
Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS.B-RAFV600E 抑制诱导人黑色素瘤细胞凋亡涉及 bimS 的选择性剪接。
Cell Death Dis. 2010 Sep 2;1(9):e69. doi: 10.1038/cddis.2010.48.
2
Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.致癌性BRAF(V600E)抑制BIM表达以促进黑色素瘤细胞存活。
Pigment Cell Melanoma Res. 2008 Oct;21(5):534-44. doi: 10.1111/j.1755-148X.2008.00491.x. Epub 2007 Jul 28.
3
Zinc-induced modulation of SRSF6 activity alters Bim splicing to promote generation of the most potent apoptotic isoform BimS.锌诱导的 SRSF6 活性调节改变 Bim 的剪接,从而促进最有效的凋亡同工型 BimS 的产生。
FEBS J. 2013 Jul;280(14):3313-27. doi: 10.1111/febs.12318. Epub 2013 Jun 3.
4
Evidence for upregulation of Bim and the splicing factor SRp55 in melanoma cells from patients treated with selective BRAF inhibitors.在接受选择性 BRAF 抑制剂治疗的患者的黑素瘤细胞中,Bim 和剪接因子 SRp55 的上调证据。
Melanoma Res. 2012 Jun;22(3):244-51. doi: 10.1097/CMR.0b013e328353eff2.
5
PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression.PTEN 缺失通过抑制 BIM 表达赋予黑色素瘤细胞对 BRAF 抑制剂的耐药性。
Cancer Res. 2011 Apr 1;71(7):2750-60. doi: 10.1158/0008-5472.CAN-10-2954. Epub 2011 Feb 11.
6
Oncogenic B-RafV600E inhibits apoptosis and promotes ERK-dependent inactivation of Bad and Bim.致癌性B-RafV600E抑制细胞凋亡,并促进Bad和Bim的ERK依赖性失活。
J Biol Chem. 2008 Aug 8;283(32):22128-35. doi: 10.1074/jbc.M800271200. Epub 2008 May 27.
7
Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells.Akt3 介导的 BRAF 靶向黑色素瘤细胞抗细胞凋亡。
Cancer Res. 2010 Aug 15;70(16):6670-81. doi: 10.1158/0008-5472.CAN-09-4471. Epub 2010 Jul 20.
8
BH3-only protein silencing contributes to acquired resistance to PLX4720 in human melanoma.BH3 仅蛋白沉默导致人黑色素瘤对 PLX4720 的获得性耐药。
Cell Death Differ. 2012 Dec;19(12):2029-39. doi: 10.1038/cdd.2012.94. Epub 2012 Aug 3.
9
MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720.对 RAF 抑制剂 PLX4720 诱导的细胞凋亡具有抗性的 B-RAFV600E 黑色素瘤细胞中 MEK 非依赖性存活。
Clin Cancer Res. 2011 Feb 15;17(4):721-30. doi: 10.1158/1078-0432.CCR-10-2225. Epub 2010 Nov 18.
10
The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms.HSP90 抑制剂 XL888 通过多种机制克服了 BRAF 抑制剂耐药。
Clin Cancer Res. 2012 May 1;18(9):2502-14. doi: 10.1158/1078-0432.CCR-11-2612. Epub 2012 Feb 20.

引用本文的文献

1
Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure-Based Virtual Screening.基于结构的虚拟筛选鉴定新型CLK4抑制剂及其对胰腺癌中可变剪接的生物学评价
Adv Sci (Weinh). 2025 May;12(19):e2416323. doi: 10.1002/advs.202416323. Epub 2025 Mar 24.
2
Roles and mechanisms of aberrant alternative splicing in melanoma - implications for targeted therapy and immunotherapy resistance.异常可变剪接在黑色素瘤中的作用和机制——对靶向治疗和免疫治疗耐药性的影响
Cancer Cell Int. 2024 Mar 10;24(1):101. doi: 10.1186/s12935-024-03280-x.
3
Determinants for Antitumor and Protumor Effects of Programmed Cell Death.

本文引用的文献

1
2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2.2-脱氧-D-葡萄糖通过 XBP-1 介导的 TRAIL-R2 上调增强 TRAIL 诱导的人黑色素瘤细胞凋亡。
Mol Cancer. 2009 Dec 14;8:122. doi: 10.1186/1476-4598-8-122.
2
The SR protein family.SR 蛋白家族。
Genome Biol. 2009;10(10):242. doi: 10.1186/gb-2009-10-10-242. Epub 2009 Oct 27.
3
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches.可变剪接调控机制:来自分子和基因组学方法的见解
程序性细胞死亡的抗肿瘤和促肿瘤作用的决定因素。
Cancer Immunol Res. 2024 Jan 3;12(1):7-16. doi: 10.1158/2326-6066.CIR-23-0321.
4
Bcl-2 family inhibitors sensitize human cancer models to therapy.Bcl-2 家族抑制剂可增强人类癌症模型对治疗的敏感性。
Cell Death Dis. 2023 Jul 17;14(7):441. doi: 10.1038/s41419-023-05963-1.
5
How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors.驱动癌基因如何在肿瘤中塑造可变剪接机制并受其塑造。
Cancers (Basel). 2023 May 26;15(11):2918. doi: 10.3390/cancers15112918.
6
Proteotoxic stress-induced apoptosis in cancer cells: understanding the susceptibility and enhancing the potency.蛋白质毒性应激诱导的癌细胞凋亡:了解易感性并增强效力。
Cell Death Discov. 2022 Oct 4;8(1):407. doi: 10.1038/s41420-022-01202-2.
7
Targeting Splicing Factor SRSF6 for Cancer Therapy.靶向剪接因子SRSF6用于癌症治疗。
Front Cell Dev Biol. 2021 Nov 30;9:780023. doi: 10.3389/fcell.2021.780023. eCollection 2021.
8
The MEK/ERK Network as a Therapeutic Target in Human Cancer.MEK/ERK 网络作为人类癌症的治疗靶点。
Mol Cancer Res. 2021 Mar;19(3):361-374. doi: 10.1158/1541-7786.MCR-20-0687. Epub 2020 Nov 2.
9
Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer.丝氨酸/精氨酸丰富的剪接因子:连接可变剪接和癌症的桥梁。
Int J Biol Sci. 2020 Jul 6;16(13):2442-2453. doi: 10.7150/ijbs.46751. eCollection 2020.
10
Transcription factor GLIS3: Critical roles in thyroid hormone biosynthesis, hypothyroidism, pancreatic beta cells and diabetes.转录因子 GLIS3:在甲状腺激素生物合成、甲状腺功能减退症、胰岛β细胞和糖尿病中的关键作用。
Pharmacol Ther. 2020 Nov;215:107632. doi: 10.1016/j.pharmthera.2020.107632. Epub 2020 Jul 18.
Nat Rev Mol Cell Biol. 2009 Nov;10(11):741-54. doi: 10.1038/nrm2777. Epub 2009 Sep 23.
4
Human melanoma cells under endoplasmic reticulum stress are more susceptible to apoptosis induced by the BH3 mimetic obatoclax.内质网应激状态下的人黑色素瘤细胞对BH3模拟物奥巴克拉诱导的凋亡更敏感。
Neoplasia. 2009 Sep;11(9):945-55. doi: 10.1593/neo.09692.
5
Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site.人类皮肤黑色素瘤;NRAS和BRAF突变频率与组织发生亚类及身体部位关系的综述
Mol Oncol. 2008 Apr;1(4):395-405. doi: 10.1016/j.molonc.2007.12.003. Epub 2007 Dec 28.
6
Mitogen-activated protein kinase inhibition induces translocation of Bmf to promote apoptosis in melanoma.丝裂原活化蛋白激酶抑制诱导Bmf易位以促进黑色素瘤细胞凋亡。
Cancer Res. 2009 Mar 1;69(5):1985-94. doi: 10.1158/0008-5472.CAN-08-3934. Epub 2009 Feb 24.
7
The spliceosome as target for anticancer treatment.作为抗癌治疗靶点的剪接体
Br J Cancer. 2009 Jan 27;100(2):228-32. doi: 10.1038/sj.bjc.6604801. Epub 2008 Nov 25.
8
Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic.用MEK抑制剂治疗B-RAF突变的人类肿瘤细胞需要Bim,并且可被一种BH3模拟物增强。
J Clin Invest. 2008 Nov;118(11):3651-9. doi: 10.1172/JCI35437. Epub 2008 Oct 23.
9
Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.致癌性BRAF(V600E)抑制BIM表达以促进黑色素瘤细胞存活。
Pigment Cell Melanoma Res. 2008 Oct;21(5):534-44. doi: 10.1111/j.1755-148X.2008.00491.x. Epub 2007 Jul 28.
10
Oncogenic BRAF regulates melanoma proliferation through the lineage specific factor MITF.致癌性BRAF通过谱系特异性因子MITF调节黑色素瘤增殖。
PLoS One. 2008 Jul 16;3(7):e2734. doi: 10.1371/journal.pone.0002734.